Skip to main content Accessibility help
×
×
Home

Pharmacological treatment of bipolar depression

  • Gustavo H. Vázquez, Leonardo Tondo, Juan Undurraga, Rodolfo Zaratiegui, Valerio Selle and Ross J. Baldessarini...

Summary

Bipolar depression remains a major challenge for psychiatric therapeutics. It is associated with disability and excess mortality, and accounts for three-quarters of the time spent in morbid states by treated patients with bipolar disorder. Major limitations of research on the treatment of depression in bipolar disorder include a paucity of short-term and lack of long-term trials, probably reflecting concern about inducing mania. In addition, polytherapy with multiple drugs appears to be widespread, but it is virtually untested for efficacy and safety. Here, we summarise the evidence concerning efficacy of treatment of bipolar depression with antidepressants, mood-stabilising anticonvulsants, lithium and second-generation antipsychotics.

LEARNING OBJECTIVES

  1. Gain critical appreciation of the paucity of research on the treatment of bipolar depression.
  2. Rationally balance the benefits and risks of using antidepressants in patients with bipolar disorder.
  3. Assess the evidence supporting a range of research-based treatment options for bipolar depression.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Pharmacological treatment of bipolar depression
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Pharmacological treatment of bipolar depression
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Pharmacological treatment of bipolar depression
      Available formats
      ×

Copyright

Corresponding author

Dr Gustavo Vázquez, Department of Neuroscience, Palermo University, Buenos Aires, Argentina. Email: gvazquez@palermo.edu

Footnotes

Hide All

Declaration of Interest

None.

Footnotes

References

Hide All
Baldessarini, RJ, Tondo, L, Davis, P et al (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disorders, 8: 625–39.
Baldessarini, R, Henk, H, Sklar, A et al (2008) Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatric Services, 59: 1175–83.
Baldessarini, RJ, Salvatore R Khalsa, HM et al (2010a) Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disorders, 12: 264–70.
Baldessarini, RJ, Vieta, E, Calabrese, JR et al (2010b) Bipolar depression: overview and commentary. Harvard Review of Psychiatry, 18: 143–57.
Baldessarini, RJ, Tondo, L, Ghiani, C et al (2010c) Discontinuation rate vs. recurrence risk following long-term antidepressant treatment in major depressive disorder patients. American Journal of Psychiatry, 167: 934–41.
Baldessarini, RJ, Undurraga, J, Vázquez, GH et al (2012) Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatrica Scandinavica, 125: 293302.
Baldessarini, RJ (2013a) Chemotherapy in Psychiatry. Springer Press.
Baldessarini, RJ, Faedda, GL, Offidani, E et al (2013b) Rate of new-onset mania or hypomania in patients diagnosed with unipolar major depression. Journal of Affective Disorders, 148: 129–35.
Brown, EB, McElroy, SL, Keck, PE Jr et al (2006) Seven-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. Journal of Clinical Psychiatry, 67: 1025–33.
Centorrino, F, Masters, GA, Talamo, A et al (2012) Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics. Human Psychopharmacology 27: 521–6.
Cipriani, A, Hawton, K, Stockton, S et al (2013) Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ (Clinical Research), 346: f3646.
Cookson, J, Keck, PE Jr, Ketter, TA et al (2007) Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. International Clinical Psychopharmacology, 22: 93100.
Crump, C, Sundquist, K, Winkleby, MA et al (2013) Comorbidities and mortality in bipolar disorder: Swedish national cohort study. JAMA Psychiatry, 70: 931–9.
DelBello, MP, Chang, K, Welge, A et al (2009) A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disorder, 11: 483–93.
Frye, MA, Ha, K, Kanba, S et al (2011) International Consensus Group on Depression Prevention in Bipolar Disorder. Journal of Clinical Psychiatry, 72: 1295–310.
Geddes, JR, Miklowitz, DJ (2013) Treatment of bipolar disorder. Lancet, 381: 1672–82.
Ghaemi, SN, Wingo, AF, Filkowski, MA et al (2008) Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatrica Scandinavica, 118: 347–56.
Ghaemi, SN, Ostacher, MM, El-Mallakh, RS et al (2010) Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-bipolar disorder) randomized clinical trial of long-term effectiveness and safety. Journal of Clinical Psychiatry, 71: 372–80.
Gijsman, HJ, Geddes, JR, Rendell, JM, Nolen, et al (2004) Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. American Journal of Psychiatry, 161: 1537–47.
Leverich, GS, Altshuler, LL, Frye, MA et al (2006) Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilisers. American Journal of Psychiatry, 163: 232–9.
Loebel, A, Cucchiaro, J, Silva, R et al (2014) Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 171: 160–8.
Mathews, DC, Zarate, CA Jr (2013) Current status of ketamine and related compounds for depression. Journal of Clinical Psychiatry, 74: 516–7.
McElroy, SL, Weisler, RH, Chang, W et al (2010) Double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). Journal of Clinical Psychiatry, 71: 163–74.
Medda R Mauri, M, Fratta, S et al (2013) Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy. Journal of ECT, 29: 179–88.
Merikangas, KR, Jin, R, He, JP et al (2011) Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey initiative. Archives of General Psychiatry, 68: 241–51.
Muzina, DJ, Gao, K, Kemp, DE et al (2011) Acute efficacy of divalproex sodium versus placebo in mood stabiliser-naive bipolar I or II depression: double-blind, randomized, placebo-controlled trial. Journal of Clinical Psychiatry, 72: 813–9.
Nierenberg, AA, Alpert, JE, Gardner-Schuster, EE et al (2008) Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biological Psychiatry, 64: 455–60.
Ösby, U, Brandt, L, Correia, N et al (2001) Excess mortality in bipolar and unipolar disorder in Sweden. Archives of General Psychiatry, 58: 844–50.
Pacchiarotti, I, Bond, DJ, Baldessarini, RJ et al (2013) International Society for Bipolar Disorders (ISBD) task-force report on antidepressant use in bipolar disorders. American Journal of Psychiatry, 170: 1249–62.
Poon, SH, Sim, K, Sum, MY et al (2012) Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disorders, 14: 573–84.
Prasko, J, Ociskova, M, Kamaradova, D et al (2013) Bipolar affective disorder and psychoeducation. Neuroendocrinology Letters, 34: 8396.
Reinares, M, Rosa, AR, Franca, C et al (2013) A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. International Journal of Neuropsychopharmacology 16: 485–96.
Sachs, GS, Nierenberg, AA, Calabrese, JR et al (2007) Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine, 356: 1711–22.
Sanders, KEA, Goodwin, GM (2010) The course of bipolar disorder. Advances in Psychiatric Treatment, 16: 318–28.
Schaub, A, Neubauer, N, Bernhard, B et al (2013) Cognitive-psychoeducational group programme for bipolar disorder: pilot study with two-year follow-up [in German]. Fortschritte der Neurologie – Psychiatrie, 81 (suppl 1): s304.
Selle, V, Schalkwijk, S, Vázquez, GH et al (2014) Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium, and second-generation antipsychotics. Pharmacopsychiatry, 18 Feb [Epub ahead of print].
Sidor, MM, MacQueen, GM (2012) Update on antidepressant use in bipolar depression. Current Psychiatry Reports, 14: 696704.
Tamayo, JM, Zarate, CA Jr, Vieta, E et al (2010) Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: systematic review and meta-analysis. International Journal of Neuropsychopharmacology, 13: 813–32.
Tondo, L, Lepri, B, Baldessarini, RJ (2007) Suicidal risks among 2826 Sardinian major depressive disorder patients. Acta Psychiatrica Scandinavica, 116: 419–28.
Tondo, L, Vázquez, G, Baldessarini, RJ (2010) Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatrica Scandinavica, 121: 404–14.
Tondo, L, Baldessarini, RJ, Vázquez, GH et al (2013) Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatrica Scandinavica, 127: 355–64.
Tondo, L, Baldessarini, RJ, Vázquez, GH (2014) Options for pharmacological treatment of refractory bipolar depression. Current Psychiatry Reports, 16: 431.
Undurraga, J, Baldessarini, RJ (2012a) Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology, 37: 851–64.
Undurraga, J, Baldessarini, RJ, Valenti, M et al (2012b) Bipolar depression: clinical correlates of receiving antidepressants. Journal of Affective Disorders, 139: 8993.
Vázquez, GH, Tondo, L, Baldessarini, RJ (2011) Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. Pharmacopsychiatry, 44: 21–6.
Vázquez, GH, Tondo, L, Undurraga, J et al (2013) Overview of antidepressant treatment of bipolar depression. International Journal of Neuropsychopharmacology 16: 1673–85.
Yatham, LN, Kennedy, SH, Parikh, SV et al (2013) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 15: 144.
Young, AH, McElroy, SL, Bauer, M et al (2010) Double-blind, placebo-controlled study (EMBOLDEN I) of quietapine and lithium monotherapy in adults in the acute phase of bipolar depression. Journal of Clinical Psychiatry, 71: 150–62.
Zimmermann, P, Brückl, T, Nocon, A et al (2009) Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Archives of General Psychiatry, 66: 1341–52.
Zornberg, GL, Pope, HG (1993) Treatment of depression in bipolar disorder: new directions for research. Journal of Clinical Psychopharmacology 13: 397408.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 1355-5146
  • EISSN: 1472-1481
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Pharmacological treatment of bipolar depression

  • Gustavo H. Vázquez, Leonardo Tondo, Juan Undurraga, Rodolfo Zaratiegui, Valerio Selle and Ross J. Baldessarini...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *